Skip to main content
Journal ArticleOPEN ACCESS

64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors

  • Mirzaei S
  • Revheim M
  • Raynor W
  • et al.
Oncology and Therapy (2020) 8(1) 125-131
DOI: 10.1007/s40487-019-00104-1
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Several radiolabeled somato-statin analogues have been developed for molecular imaging of neuroendocrine tumors (NETs) with single-photon emission computed tomography (SPECT) and positron-emission

Cite

CITATION STYLE

APA

Mirzaei, S., Revheim, M.-E., Raynor, W., Zehetner, W., Knoll, P., Zandieh, S., & Alavi, A. (2020). 64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors. Oncology and Therapy, 8(1), 125–131. https://doi.org/10.1007/s40487-019-00104-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free